Cambridge Investment Research Advisors, Inc. Cel Sci Corp Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021
SELL
$11.05 - $16.62 $116,378 - $175,041
-10,532 Closed
0 $0
Q3 2020

Oct 29, 2020
BUY
$11.69 - $14.54 $123,119 - $153,135
10,532 New
10,532 $134,000
Q2 2020

Jul 27, 2020
SELL
$9.75 - $17.6 $97,870 - $176,668
-10,038 Closed
0 $0
Q1 2020

May 08, 2020
SELL
$7.54 - $17.05 $8,821 - $19,948
-1,170 Reduced 10.44%
10,038 $115,000
Q4 2019

Feb 04, 2020
BUY
$6.71 - $9.55 $75,205 - $107,036
11,208 New
11,208 $102,000

Others Institutions Holding CVM

# of Institutions
71
Shares Held
6M
Call Options Held
27.1K
Put Options Held
150K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $26.9M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email